STALLERGENES GREER ANNOUNCES ITS 2016 FINANCIAL CALENDAR  

February 22, 2016

STALLERGENES GREER ANNOUNCES ITS 2016 FINANCIAL CALENDAR  

London (United Kingdom) – Stallergenes Greer plc (the “Company”) (Euronext Paris: STAGR), a biopharmaceutical company specializing in treatments for respiratory allergies, today announced its financial calendar for the year 2016:

 

FY 2015 Results 27th April 2016
Investor and Analyst Call 28th April 2016
Annual Report Filing 29th April 2016
Annual General Meeting 9th June 2016
1st semester 2016 Results 25th August 2016
Strategy and R&D Day November 2016

Please note that Stallergenes Greer will release its financial results for the year 2015 the 27th of April after market close.  Fereydoun Firouz, Chief Executive Officer, and Peter Bühler, Chief Financial Officer, will host the investor and analyst call on the 28th of April at 2:00 pm (CET).

The Company’s Annual General Meeting will be held on the 9th of June in Paris, France. Stallergenes Greer will hold a Strategy and R&D Day in Antony, France in November 2016.